Neonatal Abstinence Syndrome

making it a major health concern. A vast percentage leading to the opioid crisis is due to women in their childbearing stages of life. Newborns born to women addicted to opioids suffer through a form of newborn drug withdrawal known as Neonatal abstinence syndrome (NAS), resulting in increased admission rates, prolonged length of stay in the hospital and infants often require medication to recover. NAS is a result of opioid exposure in utero characterized by “central nervous system hyperirritability

The women enrolled were exposed to methadone, buprenorphine, cigarette smoking, and drug use such as heroin and cocaine. The prenatal exposure to methadone and buprenorphine resulted in Neonatal abstinence syndrome or NAS. NAS, are problems that occur in newborns who were exposed to opiate drugs which can have problems such as withdrawals which can cause severe stress to the newly born infant. This stress may lead to the loss of neurons and hypothalamic-pituitary-adrenal

Neonatal Abstinence Syndrome (NAS) is a growing concern within the United States. This paper discusses what NAS is and the effects it has on the newborn infant. If first discusses the incidence of NAS as regard to maternal age, race, and ethnicity. It explains the types of drugs most commonly associated with Neonatal Abstinence Syndrome. However, I have excluded alcohol from this paper because it results in Fetal Alcohol Syndrome. This paper will then explain the types of physical symptoms associated

Neonatal Abstinence Syndrome is caused by the intake and abuse of drugs during pregnancy, leading to several serious problems for the baby. At birth, neonates with NAS have an increased chance of being born with birth defects or a low birthweight, causing problems in overall health or development and functionality of the body. “As a withdrawal syndrome, NAS is characterized by dysregulation in central, autonomic, and gastrointestinal system functioning” causing an array of problems for the baby (Logan

with infants and toddlers. As I worked with this age group and worked for the hospital system the topic of Neonatal Abstinence Syndrome (NAS) was as issue that we were seeing more of in our region. I became more intrigued with topic when I attended a local infant/toddler conference and the opening panel spoke about NAS. In this research paper, I will be addressing what neonatal abstinence syndrome is, how NAS is effecting Tennessee, and what infant caregivers can do to help support these young

I chose to review Mariah Hish's nurse analysis presentation titled "Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure." I chose this presentation because I am a Neonatal Intensive Care nurse (NICU) and often deal with infants who suffer from neonatal abstinence syndrome (NAS). Infants who suffer from NAS are born to drug-addicted mothers, and due to the drug use in utero, they display "symptoms that reflect a physiologic dependence on opioids, resulting in central nervous system

Neonatal abstinence syndrome (NAS) is a group of problems that occur in a newborn who was exposed to addictive opiate drugs while in the mother’s womb. This happens when a pregnant woman takes drugs such as heroin, codeine, inhalants, marijuana, methamphetamine, nicotine, prescription or even over-the-counter drugs. Many substances pass easily through the placenta, some substances that a pregnant woman takes also, to some degree, reach the baby (Neonatal abstinence syndrome, 2014). Just like adults

Neonatal Abstinence Syndrome (NAS), as defined by Lee, Zieve, and Ogilvie (2014), is a grouping of problems that manifest in newborns when the mother takes addictive substances, primarily opiates, for an extended period of time exposing the fetus to the drugs while in the womb. A number of drugs that have been linked to NAS include: heroin, codeine, oxycodone, methadone and buprenorphine. Although these are commonly used for recreation, NAS can also manifest from proper use of certain prescription

In order to properly treat Neonatal Abstinence Syndrome, if first must be established the severity to determine what type of treatment would be most effective. The most common scoring system for NAS is known as the Finnegan Neonatal Abstinence Severity Score; “positive symptoms are given a weighted score and summed every four hours; decisions regarding treatment onset and rate are made based on a cumulative threshold score” (Logan et al., 2014, p.3). Depending on the neonate’s Finnegan score, the

known about Opiate drug usage is that pregnant women using this drug give birth to babies with neonatal abstinence syndrome. Babies being born going through withdrawal because the fetus is no longer receives the drug. It was found that neonatal abstinence syndrome is passed when the drug is in the mother's bloodstream which then passes through the placenta into the fetus. Symptoms of neonatal abstinence syndrome in babies vary depending on how much opiate was used during the pregnancy. It includes premature